![Siri Dandu](/sites/default/files/styles/400x560_student_/public/pictures/2023-09/screen-shot-2023-09-12-at-5.21.56-pm.png?h=cc73f99b&itok=JDetkfqs)
Siri Dandu
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts
Cell-Free DNA Methylation as a Biomarker of Malignant vs. Benign Lung Nodules: Cross-Validation of 2022 and 2023 Patient Cohorts